Amarin Corp. (AMRN): Hitting The Thesis Reset Button, Hold
Amarin is struggling to maintain growth as generics. It is banking on the European markets to drive growth in the coming years. Read to know why it's a Hold.
Source: seekingalpha.com
Stay updated with breaking news from Bold Thesis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amarin is struggling to maintain growth as generics. It is banking on the European markets to drive growth in the coming years. Read to know why it's a Hold.